| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |